GlassScriptPhysician profile
Ravinder Clayton
NPI 1245635747
$2,644.59
in general payments reported to CMS, 2019-2025
10 companies · $949 in 2025
The $949 reported for 2025 was more than what 83% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.35 · 2022: $236 · 2023: $126 · 2024: $1,279 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,367 · Travel and Lodging: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.58 |
| Travel and Lodging | $987.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,193.23 | 2024-2025 | Varian Ethos Treatment Planning, Eclipse Treatment Planning System For External Beam Radiation Therapy |
| Brainlab, INC. | $447.41 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Elekta, INC. | $272.12 | 2024-2025 | Elekta Unity, Flexitron Hdr, Elekta Medical Linear Accelerator |
| Intuitive Surgical, INC. | $177.09 | 2022-2025 | |
| Galvanize Therapeutics, INC | $151.88 | 2025 | Aliya System |
| Canon Medical Systems USA, INC. | $126.47 | 2023 | Ct Scanner |
| Zap Surgical Systems, INC. | $126.24 | 2022 | |
| Novocure INC. | $83.13 | 2025 | Optune Lua (Novottf-200t) |
| Varian Medical Systems, INC. | $54.35 | 2019 | |
| Astellas Pharma US INC | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravinder Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.